Brind.

Financial firms are providing buy ratings and price targets for Compass, Inc., while the NY AG office investigates market position from an antitrust perspective.

Steady: 0 in the last 7 days Updated oct 6

The latest in this situation

  1. Compass faces a new antitrust lawsuit in the Southern District.
  2. A Health Promotion Board, along with industry partners, is expanding the market availability of lower-sodium alternatives.

How it started

2 reports, 2 independent, last reported Oct 6. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Financial firms are providing buy ratings and price targets for Compass, Inc., while the NY AG office investigates market position from an antitrust perspective.

Who's involved

What this event is mainly about
Deutsche Bank

How it developed

Newest first. Tap a step to see who reported it.
  1. Compass faces a new antitrust lawsuit in the Southern District.1 source
  2. A partnership involving Compass and MRED is facing federal scrutiny regarding market practices.Sub-event
  3. Buy ratings and antitrust investigation into Compass, Inc.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped